Rep. Matt Gaetz, Trump Ally, Sponsors Medical Pot Bill
*By Jacqueline Corba*
Freshman Congressman Matt Gaetz (R-FL) is on a mission to pass a bill that would allow for expanded medical marijuana research.
"Research can demystify who is right and who is wrong," Gaetz told Cheddar's CannaBiz Tuesday. "It's kind of nice to let the science guide our policy making."
Last week, the [Medical Marijuana Act](https://gaetz.house.gov/media/press-releases/congressman-matt-gaetz-applauds-passage-medical-cannabis-bill-through-house) sponsored by Gaetz passed the U.S. House Judicial Committee with bipartisan support.
It's a "landmark moment" Gaetz said; it's the first time Republicans in control of Congress have passed a medical marijuana bill through committee. Next it will head to the House floor for a vote.
"I'm super excited about what potential cannabis has in healthcare, and I think we'll learn a lot more if we're not so stupid as a government to make the research illegal," Gaetz said.
The act would give research institutions "safe harbor" to study the potential uses, benefits, and risks of the drug, which remains a Schedule I classification under the federal law alongside heroin and LSD.
"I think that marijuana policy has in many ways been victimized by the overall chilled relationship between the White House and the Department of Justice," Gaetz said.
"I think it is really Jeff Sessions who opposes medical marijuana, and I'm not entirely sure he and President Trump will be on one another's Christmas lists going forward."
For Gaetz, Washington is obstructing its own view.
"Washington just needs to get out of the way so that we can really see the potential."
For full interview [click here](https://cheddar.com/videos/medical-cannabis-research-act-passes-first-hurdle-in-congress).
The Biden administration will not send an official U.S. delegation to the 2022 Winter Olympics in Beijing as a statement against China's "ongoing genocide and crimes against humanity in Xinjiang." Weifeng Zhong, senior research fellow at George Mason University's Mercatus Center, joins Cheddar News to discuss the boycott.
Back in 2010, several large companies pledged to work towards stopping deforestation by 2020. Companies like Nestle and Carrefour even went further to say that they would eliminate deforestation from their supply chains altogether. However, fast forward to 2020, many of these companies have failed to reach that goal. Associate Director of Forest at the CDP Nadia Bishai, joined Cheddar to discuss more.
Instagram Chief Executive Adam Mosseri is set to testify before Congress for the first time. Mosseri’s appearance follows reports that showed Facebook and Instagram are aware of the harms their apps and services cause, including to teen mental health. Nicole Gill, co-founder and executive director of Accountable Tech joins Cheddar News to preview the hearing.
Chamber of Progress CEO Adam Kovacevich joined Wake Up With Cheddar to break down what to expect from the cryptocurrency executives appearing on Capitol Hill and how it could impact future crypto regulation. "I think what most people want to see from regulation is essentially channeling the good and the potential and putting in place guardrails to minimize the bad," he said.
Markets opened higher as investors shrugged off weaker-than-expected job growth and Omicron fears. George Seay, CEO, Annandale Capital joined Cheddar's Opening Bell to discuss.
Less than six months after making its public debut on the NYSE, Chinese ride-hailing giant Didi says it will delist in the U.S. and pivot to Hong Kong instead. Chinese regulators are citing cybersecurity and data concerns. Shehzad Qazi, Managing Director, China Beige Book International joined Cheddar's Opening Bell to discuss.
While the World Health Organization strongly advises against a COVID-19 vaccine mandate, national and local governments are moving to make inoculations compulsory. Cheddar News speaks with Dr. Joel Zinberg of the Competitive Enterprise Institute on the issue.
